This summary was created by AI, based on 9 opinions in the last 12 months.
Great West Lifeco (GWO-T) is recognized for its disciplined and methodical acquisition strategy and its strong global platform, operating in Canada, the US, and Europe. Many experts highlight its appeal for income-oriented investors, given its attractive yield of around 4.6% to 5.4% and a diverse revenue stream from asset management, insurance, and annuities. There is optimism about future earnings growth, particularly from the US market, benefitting from the weaker Canadian dollar. While some analysts suggest that the stock has been performing well, they recommend patience and participation in dividend reinvestment programs, citing potential market fluctuations due to interest rates. Although some warn of possible challenges ahead, the overall sentiment leans towards being a solid long-term investment with stable dividend growth and a strong market position.
All the insurance names, both in Canada and the US, continue to work. If interest rates do, in fact, go higher, that will only be beneficial for lifecos and other insurers. The chart looks fantastic. Good run, so there is some weakening in the intermediate term.
If a long-term holding, best thing you can do is sit on your hands and do nothing except participate in the DRIP program. Especially if he's right on the broader call of rates being 8-10% in the secular bear market of 2030-40, should be a big tailwind for insurers.
Both companies have done quite well and both are cheap with secure dividends. It has been a good year for the sector but they may not get the same returns going forward.
Revenues from asset management, insurance, annuities, health benefits. Very diversified. Around for decades. Likes the safety and growth over time. Dividend growth is about 8%. Payout ratio still in 50-70% range. High quality. Not necessarily a home run, but a single: core holding for the long term, dividend payments, some price appreciation. Yield is 4.6%.
Because it's diversified, interest rate moves benefit different segments at different times.
Great company, high quality. More focused on investments than some of the other insurance companies. Hitting new highs.
For income-oriented investors. Mature market focus in Canada, US, and mature parts of Europe; whereas MFC and SLF are pursuing growth more in EMs. Better on capital allocation, likes growth potential. Trades at less than 10x earnings. Attractive yield of 5.2%.
(Analysts’ price target is $44.20)Likes it, screens well. Decent price to book ratio, attractive relative to other names today. Shares have come down with the correction, mainly due to interest rates popping up a bit. Affected by interest rates. Quality, good management. Yield is 5.4%, strong.
On a total return basis including dividends, the return in positive; without the dividend, it looks negative. So you have to hold this a long time to ride out the fluctuations as you collect the dividends.
Earnings were underwhelming. A more expensive stock in the insurance space. Insurance companies are set up to continue to outperform the banks. Everyone's looking for yield. Look to MFC as #1 in the space.
His best guess is that GWO might be the best performer of the 3. Not particularly liquid, but shouldn't be an issue for the retail investor. Insurance companies tend to do well in a rising rate environment, because it tends to discount their liabilities to a degree.
It has done extremely well and has good client retention.
Decent valuation at 6.5x PE, very good yield of about 5.17%. Dividend yield remains stable and sustainable, growing about 3-4%. Higher interest rates are benefitting. Low beta, about 90% of the TSX.
His preference is for quality. He likes POW, which owns GWO, for dividend growth and share buybacks. AGF.B might have higher return potential because it's smaller with more volatility, but POW will give him a higher Sharpe ratio over the long term because it's not as volatile.
Prefers the banks to the lifecos, of which he owns none. Lifecos have been sluggish growers. It yields 6%, but share appreciation is better among banks. Other lifecos have overseas operations and therefore more growth.
Great West Lifeco is a Canadian stock, trading under the symbol GWO-T on the Toronto Stock Exchange (GWO-CT). It is usually referred to as TSX:GWO or GWO-T
In the last year, 5 stock analysts published opinions about GWO-T. 3 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Great West Lifeco.
Great West Lifeco was recommended as a Top Pick by on . Read the latest stock experts ratings for Great West Lifeco.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered Great West Lifeco In the last year. It is a trending stock that is worth watching.
On 2025-02-21, Great West Lifeco (GWO-T) stock closed at a price of $52.09.
Really likes it for income. Very disciplined and methodical acquisitions. Global platform: Canada, US, and Europe. Recent earnings growth was from US side, and this will likely continue due to demand and to weak CAD. Above his buy price, so just wait a bit. Yield is 4.7%.